# Preserving Geriatric Muscle With an Osteoporosis Medication

> **NCT06118905** · PHASE4 · RECRUITING · sponsor: **Susan L. Greenspan** · enrollment: 155 (estimated)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Denosumab 60 MG/ML
- **DRUG:** Zoledronic Acid 5Mg/Bag 100Ml Infusion

## Key facts

- **NCT ID:** NCT06118905
- **Lead sponsor:** Susan L. Greenspan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-08
- **Primary completion:** 2029-02-28
- **Final completion:** 2029-03-31
- **Target enrollment:** 155 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06118905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06118905, "Preserving Geriatric Muscle With an Osteoporosis Medication". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06118905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*